WEBINAR

CNS Clinical Research challenges on 15th Oct,2010

Speaker: Dr. Jeroze J. Dalal , Dr MS Reddy

PACE is bringing together industry and academicians to explore the current and future opportunities within Clinical research in CNS, which is the fastest growing therapeutic segment in India and as well as globally. The major focus would be on neurodegenerative disorders. The webinar aims to cover clinical research activities, challenges and opportunities as well as effective way to overcoming the low patient recruitment rates in CNS clinical trials.

To enhance productivity and growth in this field, there has been an increased awareness needed to align sponsor, PI and patients. It is also primarily designed to serve the ongoing academic, research, and practice based needs of its members. It will also serve as an invaluable informational resource and portal for professionals working in this field.

Key points under discussion include:

  • Bullet Understanding CNS Disease Specific Therapeutics
  • Bullet Measuring Cognition and Mental Wellbeing in patients
  • Bullet Overcoming the Low Patient Recruitment Rates in CNS Clinical Trials
  • Operational Challenges

Webinar: From your own Desk (Internet connection and head set speakers)

Who should participate? Physicians, Medical Advisors, Medical Directors, Investigators, Clinical professionals in Medical / Healthcare / Pharmaceutical / Biotech industries.

About MakroCare:
MakroCare is an international drug development services firm that is dedicated to efficient, high-level performance in combination with unparalleled client satisfaction. MakroCare has 4 subsidiaries/divisions – CRO, Consulting, SMO and Informatics. MakroCare has teams positioned worldwide in these divisions supporting regulatory affairs, risk management, trial management (clinical, late phase), monitoring, biometrics (cdm, edc, biostat, sas programming, medical writing), QA audits, drug safety/pharmacovigilance, site management, patient recruitment, informatics (edc, ctms, ivrs), and various aspects of drug development.